Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Active Not Recruiting1
Enrolling By Invitation1
Recruiting1

Clinical Trials (3)

Showing 3 of 3 trials
NCT04162171Not ApplicableRecruiting

Cohort Study - SBRT for VT Radioablation

NCT05524077Not ApplicableActive Not RecruitingPrimary

Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia

NCT05932615Not ApplicableEnrolling By Invitation

ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation

Showing all 3 trials

Research Network

Activity Timeline